Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of hemostatic agent and preparation method thereof

A hemostatic agent and monarch drug technology, applied in the field of medicine, can solve problems such as wound infection, excessive blood loss, and life-threatening injuries, and achieve the effect of easy processing and no toxic side effects

Active Publication Date: 2021-02-26
JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Existing hemostatic drugs are insufficient in hemostasis speed, especially for more serious wounds, which may lead to excessive blood loss due to insufficient hemostasis speed, which will cause the wounded to be life-threatening; When hemostasis must have astringent and antipruritic effects at the same time, the condition is prolonged because there is no suitable hemostatic drug; there are also some drugs that use chemicals to achieve rapid hemostasis, which has a faster hemostasis speed, but the possibility of infection on the wound cannot be ruled out

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of hemostatic agent and preparation method thereof
  • A kind of hemostatic agent and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A hemostatic agent, the hemostatic agent comprises a monarch drug, a subordinate drug, and an adjuvant drug, in parts by mass, the monarch drug includes 60 parts of Galla gall, 60 parts of Angelica dahurica; the subject drug includes 20 parts of dried alum and 20 parts of Bletilla striata; The adjuvant comprises 10 parts of borneol.

[0016] A preparation method of hemostatic agent, comprising the following steps:

[0017] Weigh gallnut, angelica dahurica, bletilla striata, and dried alum in the above amounts, pulverize them into coarse powder, pulverize them for 3 minutes, add borneol and mix well to obtain.

Embodiment 2

[0019] A hemostatic agent, the hemostatic agent includes a monarch drug, a ministerial drug, and an adjuvant drug, in parts by mass, the monarch drug includes 50 parts of Galla gall, 50 parts of Angelica dahurica; the subject drug includes 20 parts of dry alum, 20 parts of bletilla striata; Described adjuvant comprises 10 parts of Borneol, and its preparation method comprises the following steps:

[0020] (1) Weigh gallnut, angelica dahurica, bletilla striata, and dried alum in the above amounts, grind them into coarse powder, and ultrafinely pulverize them for 3 minutes.

[0021] (2) Oil phase: 400g cetyl alcohol, 100g glyceryl monostearate, 200g paraffin, 400g vaseline, 200g Span-60 and heat to 80°C to melt;

[0022] (3) Heat the water phase Tween-80 500g, glycerin 300g, and double distilled water 3000mL to 80°C, add the superfine powder of medicinal materials and stir evenly;

[0023] (4) Add the oil phase to the water phase, stir evenly, cool naturally to 40°C, add borneo...

Embodiment 3

[0025] A hemostatic agent, the hemostatic agent comprises a monarch drug, a ministerial drug, and an adjuvant drug, in parts by mass, the monarch drug includes 40 parts of Galla gall, 40 parts of Angelica dahurica; the subject drug includes 20 parts of dry alum, 20 parts of Bletilla striata; Described adjuvant comprises 10 parts of Borneol, and its preparation method comprises the following steps:

[0026] (1) Weigh gallnut, angelica dahurica, bletilla striata, and dried alum in the above amounts, grind them into coarse powder, and ultrafinely pulverize them for 3 minutes.

[0027] (2) Oil phase: Heat 400g of cetyl alcohol, 100g of glyceryl monostearate, 200g of paraffin, 400g of petrolatum, and 200g of Span-60 to 80°C and melt;

[0028] (3) Heat the water phase Tween-80 500g, glycerin 300g, and double distilled water 3000mL to 80°C, add the superfine powder of medicinal materials and stir evenly;

[0029] (4) Add the oil phase to the water phase, stir evenly, cool naturally ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a hemostatic agent and a preparation method thereof. The hemostatic agent comprises a monarch drug, a minister drug and an adjuvant drug. In terms of parts by mass, the monarch drug is 40-60 parts of Galla chinensis and 10-60 parts of Angelica dahurica; The ministerial drug is 20 parts of dried alum and 20 parts of Bletilla striata; the adjuvant drug is 10 parts of borneol. The hemostatic agent of the present invention has astringent and hemostatic effects, can realize the purpose of quick hemostasis of the wound, and is convenient for processing; all prescriptions are prepared from traditional Chinese medicines, are safe and reliable, and have no toxic and side effects. It is mainly used for various bleeding symptoms such as bruises, stasis, swelling and pain, hematemesis, hemoptysis, blood in the stool, hemorrhoids, metrorrhagia, etc. The preparation method of the hemostatic agent is to prepare the prescription Chinese medicine into superfine powder or ointment.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a hemostatic drug. Background technique [0002] Bleeding from internal and external injuries due to various reasons is very common in daily life, so hemostatic drugs are used to stop bleeding from wounds and are widely used. Existing hemostatic drugs are insufficient in hemostasis speed, especially for more serious wounds, which may lead to excessive blood loss due to insufficient hemostasis speed, thereby causing life-threatening injuries to the injured; When hemostasis must have astringent and antipruritic effects at the same time, the condition is prolonged because there is no suitable hemostatic drug; there are also some drugs that use chemicals to achieve rapid hemostasis, which has a faster hemostasis speed, but the possibility of infection on the wound cannot be ruled out. Contents of the invention [0003] The object of the present invention is to provide a hemostatic agent wi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/898A61P7/04A61K35/64A61K33/06A61K31/045
CPCA61K36/898A61K31/045A61K33/06A61K35/63A61K36/232A61K2300/00
Inventor 陈浩管咏梅张建林张磊昌谢昌营臧振中
Owner JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products